Q-omics provides the consensus-scored RNY4P29 profile across patient tissues and cancer cell-line models. RNY4P29 expression is associated with patient survival in 9 of 34 cancer types, with the highest sampling consensus in LIHC. Additionally, RNY4P29 RNA expression shows 5,481 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight LIHC, and STAD as cancer lineages where RNY4P29 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for RNY4P29 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes RNY4P29 survival associations across molecular data types. RNY4P29 RNA expression shows survival associations in the most cancer types (9). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

RNY4P29 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	9	LIHC (54)	view →

This table ranks reproducible RNY4P29 RNA expression–survival associations across cancer types. High RNY4P29 expression shows unfavorable associations in LIHC, DLBC, ESCA, TGCT, PAAD and BLCA. The LIHC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify LIHC as the clearest survival context for RNY4P29 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	DFS	Tertile	All	0.042	0.545	<.001	54	view →
DLBC	DFS	Tertile	II,III,IV	0.065	0.829	<.001	45	view →
ESCA	OS	Tertile	IV	0.095	0.512	.008	36	view →
TGCT	DFS	Tertile	II,III,IV	0.015	0.919	<.001	36	view →
PAAD	OS	Tertile	II,III,IV	0.213	0.556	.014	36	view →
BLCA	DFS	Tertile	All	0.187	0.597	.025	18	view →

Pink = unfavorable, green = favorable. all 9 lineages →

RNY4P29-LIHC (DFS)

Kaplan–Meier survival curve for RNY4P29 RNA expression in LIHC: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with RNY4P29 in patient tissues and cancer cell lines. In patient samples, RNY4P29 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Function (RNA)	5,481	STAD (5392)	view →
RNA	4,536	STAD (2055)	view →